CRRTF - Crescita Therapeutics GAAP EPS of $0.06 revenue of $6M
2023-03-15 09:18:02 ET
- Crescita Therapeutics press release ( OTCPK:CRRTF ): Q4 GAAP EPS of C$0.06.
- Revenue of C$6M (-20.6% Y/Y).
- Gross profit was $3,885 compared to $4,651, down $766;
- Operating expenses were $3,313 compared to $3,536, down $223;
- Adjusted EBITDA was $997 compared to $1,585, down $588;
For further details see:
Crescita Therapeutics GAAP EPS of $0.06, revenue of $6M